Page last updated: 2024-09-04

ezetimibe and Arteriosclerosis

ezetimibe has been researched along with Arteriosclerosis in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (85.71)	29.6817
2010's	1 (7.14)	24.3611
2020's	1 (7.14)	2.80

Authors

Authors	Studies
Bea, AM; Benaiges, D; Blanco-Vaca, F; Brea-Hernando, Á; Climent, E; Pedro-Botet, J; Perea, V; Pintó, X; Plana, N; Suárez-Tembra, M	1
Fukumoto, Y	1
Brown, WV	1
Brown, AJ	1
Huff, MW	1
Jialal, I; Kappagoda, T	1
Kane, J; Kwiterovich, P; Lütjohann, D; Musliner, T; Musser, B; Patel, SB; Salen, G; Stein, P; von Bergmann, K	1
Kroemer, HK; Meyer Zu Schwabedissen, H	1
Bauersachs, J; Ertl, G; Hu, K; Huang, PL; Kuhlencordt, PJ; Padmapriya, P; Rützel, S; Schäfer, A; Schödel, J	1
Yamashita, S	1
Meng, CQ	1
Compton, DS; Davis, HR; Hoos, L; Tetzloff, G	1
Rudel, LL	1
Bruckert, E; Gagné, C; Gaudet, D	1

Reviews

5 review(s) available for ezetimibe and Arteriosclerosis

Article	Year
Promising therapies for cholesterol reduction. Managed care (Langhorne, Pa.), 2002, Volume: 11, Issue:9 Suppl Topics: Allylamine; Anticholesteremic Agents; Arteriosclerosis; Azetidines; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, LDL; Colesevelam Hydrochloride; Ezetimibe; Glycoproteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Receptors, Cytoplasmic and Nuclear; Sterol O-Acyltransferase; Sulfonic Acids; Transcription Factors; United States	2002
Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis. The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 2003,Winter, Volume: 10 Suppl A Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Azetidines; Cholesterol; Cholesterol, Dietary; Chylomicrons; Clinical Trials as Topic; Ezetimibe; Humans; Intestinal Absorption; Lipoproteins; Postprandial Period	2003
[Ezetimib]. Deutsche medizinische Wochenschrift (1946), 2004, Sep-24, Volume: 129, Issue:39 Topics: Anticholesteremic Agents; Arteriosclerosis; Azetidines; Coronary Disease; Ezetimibe; Humans; Hypercholesterolemia; Hyperlipoproteinemias	2004
[Other antihyperlipidemic drugs with novel mechanism]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3 Topics: Animals; Arteriosclerosis; Azetidines; Benzylamines; Carrier Proteins; CCAAT-Enhancer-Binding Proteins; Chenodeoxycholic Acid; Cholesterol; Coronary Disease; Diphosphonates; DNA-Binding Proteins; Ezetimibe; Farnesyl-Diphosphate Farnesyltransferase; Humans; Hyperlipidemias; Hypolipidemic Agents; Lithocholic Acid; Organic Anion Transporters, Sodium-Dependent; Oxygenases; Squalene Monooxygenase; Sterol Regulatory Element Binding Protein 1; Symporters; Thiophenes; Transcription Factors	2001
Preclinical and clinical pharmacology of a new class of lipid management agents. The American journal of managed care, 2002, Volume: 8, Issue:2 Suppl Topics: Absorption; Animals; Anticholesteremic Agents; Arteriosclerosis; Azetidines; Cholesterol, LDL; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ezetimibe; Mice; Rats	2002

Trials

2 trial(s) available for ezetimibe and Arteriosclerosis

Article	Year
Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation, 2004, Mar-02, Volume: 109, Issue:8 Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoproteins B; Arteriosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Azetidines; Child; Cholesterol; Cholesterol, Dietary; Double-Blind Method; Ezetimibe; Female; Genes, Recessive; Humans; Intestinal Absorption; Lipid Metabolism, Inborn Errors; Lipoproteins; Male; Middle Aged; Phytosterols; Sitosterols; Treatment Outcome	2004
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation, 2002, May-28, Volume: 105, Issue:21 Topics: Adolescent; Adult; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Azetidines; Blood Component Removal; Child; Cholesterol, LDL; Creatine Kinase; Diet Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Ezetimibe; Female; Heptanoic Acids; Homozygote; Humans; Hyperlipoproteinemia Type II; Liver Function Tests; Male; Pyrroles; Simvastatin; Treatment Outcome	2002

Article

Year

Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia.

Circulation, 2004, Mar-02, Volume: 109, Issue:8

Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoproteins B; Arteriosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Azetidines; Child; Cholesterol; Cholesterol, Dietary; Double-Blind Method; Ezetimibe; Female; Genes, Recessive; Humans; Intestinal Absorption; Lipid Metabolism, Inborn Errors; Lipoproteins; Male; Middle Aged; Phytosterols; Sitosterols; Treatment Outcome

2004

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.

Circulation, 2002, May-28, Volume: 105, Issue:21

Topics: Adolescent; Adult; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Azetidines; Blood Component Removal; Child; Cholesterol, LDL; Creatine Kinase; Diet Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Ezetimibe; Female; Heptanoic Acids; Homozygote; Humans; Hyperlipoproteinemia Type II; Liver Function Tests; Male; Pyrroles; Simvastatin; Treatment Outcome

2002

Other Studies

7 other study(ies) available for ezetimibe and Arteriosclerosis

Article	Year
LDL Cholesterol Reduction Variability with Different Types and Doses of Statins in Monotherapy or Combined with Ezetimibe. Results from the Spanish Arteriosclerosis Society Dyslipidaemia Registry. Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:2 Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol, LDL; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Registries; Rosuvastatin Calcium; Simvastatin	2022
[Medicines for dyslipidemia]. Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 6 Topics: Anion Exchange Resins; Arteriosclerosis; Azetidines; Dyslipidemias; Ezetimibe; Fibric Acids; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Nicotinic Acids; Probucol	2012
Atherosclerosis: cell biology and lipoproteins: cholesterol absorption inhibitors: gateway therapy for hypercholesterolaemia. Current opinion in lipidology, 2002, Volume: 13, Issue:6 Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Azetidines; Cholesterol; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Intestinal Absorption; Lipoproteins	2002
Therapy and clinical trials: ezetimibe. Current opinion in lipidology, 2003, Volume: 14, Issue:6 Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Arteriosclerosis; Azetidines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Intestinal Absorption; Mice; Mice, Knockout; Triglycerides	2003
Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice. Atherosclerosis, 2009, Volume: 202, Issue:1 Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Arteriosclerosis; Azetidines; Blood Pressure; Endothelium, Vascular; Ezetimibe; Female; Hypercholesterolemia; Inflammation; Lipids; Male; Mice; Mice, Knockout; Nitric Oxide Synthase Type III	2009
Ezetimibe (Schering-Plough). Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:3 Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Azetidines; Bile; Cholesterol; Cholesterol, LDL; Clinical Trials, Phase II as Topic; Down-Regulation; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Drugs, Investigational; Ezetimibe; Forecasting; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Intestinal Absorption; Intestinal Mucosa; Intestines; Molecular Structure; Simvastatin	2001
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:12 Topics: Administration, Oral; Animals; Anticholesteremic Agents; Aorta, Abdominal; Aorta, Thoracic; Apolipoproteins E; Arteriosclerosis; Azetidines; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Diet, Fat-Restricted; Disease Progression; Ezetimibe; Intestinal Absorption; Lipoproteins; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains	2001